Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo BID	0	21
Total, all-cause mortality	Omecamtiv Mecarbil 25 mg BID	1	21
Total, all-cause mortality	Omecamtiv Mecarbil 25 mg to 37.5 mg BID Target Dose	0	19
Total, all-cause mortality	Omecamtiv Mecarbil 25 mg to 50 mg BID Target Dose	0	20
Total, other adverse events	Placebo BID	10	21
Total, other adverse events	Omecamtiv Mecarbil 25 mg BID	8	21
Total, other adverse events	Omecamtiv Mecarbil 25 mg to 37.5 mg BID Target Dose	10	19
Total, other adverse events	Omecamtiv Mecarbil 25 mg to 50 mg BID Target Dose	11	20
Total, serious adverse events	Placebo BID	3	21
Total, serious adverse events	Omecamtiv Mecarbil 25 mg BID	4	21
Total, serious adverse events	Omecamtiv Mecarbil 25 mg to 37.5 mg BID Target Dose	1	19
Total, serious adverse events	Omecamtiv Mecarbil 25 mg to 50 mg BID Target Dose	3	20

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02695420/event-totals